The anti-seizure medication zonisamide significantly reduced the number of headache days per month in children with migraine, preliminary results of a retrospective study suggested. The data showed ...
Topiramate and zonisamide increase the risk for symptomatic kidney stones, and this risk varies by age and dosage. Topiramate and zonisamide use may increase the risk of symptomatic kidney stones, new ...
Anti-seizure drug, zonisamide has shown promise as a preventive treatment for children and adolescents living with migraine. The study will be presented at the American Academy of Neurology's 77th ...
Zonisamide, originally developed as an anticonvulsant, has been repurposed over the past two decades as an adjunctive therapy for Parkinson’s disease. Its multifaceted mechanisms—ranging from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results